Find out more about Jacques Joubert's experience
Jacques Joubert's highlights
Jacques Joubert's selected work
ICARUSS, the Integrated Care for the Reduction of Secondary Stroke trial: rationale and de..
A community survey of cardiovascular risk factors in an urban population in Botswana explo..
Regenerate: assessing the feasibility of a strength-training program to enhance the physic..
Displaying the 10 most recent scholarly works by Jacques Joubert.
ICARUSS: An effective model for risk factor management in stroke survivors
Jacques Joubert, Stephen M Davis, Geoffrey A Donnan, Christopher Levi, Graeme Gonzales, Lynette Joubert, Graeme J Hankey
Journal article | 2020 | International Journal of Stroke
BACKGROUND AND PURPOSE: After an initial stroke, the risk of recurrent stroke is high. Models that implement best-practice recomme..
ICARUSS, the Integrated Care for the Reduction of Secondary Stroke trial: rationale and design of a randomized controlled trial of a multimodal intervention to prevent recurrent stroke in patients with a recent cerebrovascular event, ACTRN=12611000264987
J Joubert, SM Davis, GJ Hankey, C Levi, J Olver, G Gonzales, GA Donnan
Journal article | 2015 | International Journal of Stroke
A community survey of cardiovascular risk factors in an urban population in Botswana exploring potential for telemedicine
J Joubert, O Nkomazana, K Mompati, L Joubert, PM Preux, P La Croix, J Laing, S Korn, B Mbogwe, B Tsima, M Cook
Journal article | 2014 | European Research in Telemedicine / La Recherche Européenne en Télémédecine
Telestroke in stroke survivors.
Jacques Joubert, Lynette B Joubert, Elizabeth Medeiros de Bustos, Dallas Ware, David Jackson, Terrence Harrison, Dominique Cadilhac
Journal article | 2009 | Cerebrovascular Diseases
Stroke is a high-frequency disorder placing a significant burden on the health care systems, being the foremost cause of complex c..
The positive effect of integrated care on depressive symptoms in stroke survivors
Jacques Joubert, Lynette Joubert, Chris Reid, David Barton, Toby Cumming, Peter Mitchell, Molly House, Robert Heng, Graham Meadows, Mark Walterfang, Christos Pantelis, David Ames, Stephen Davis
Journal article | 2008 | Cerebrovascular Diseases
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Journal article | 1998 | The Lancet
BACKGROUND: Previous trials of interferon beta in multiple sclerosis (MS) have shown efficacy, but the degree of clinical benefit ..
Medicine - St Vincent'S Hospital